Generic Peptides Duo-Blend CJC-1295 and Ipamorelin 5 mg Vial

It is a single lyophilised vial that contains two growth hormone releasing peptides, CJC-1295 without DAC and Ipamorelin, blended for laboratory work. The pack is labelled 5 mg and is supplied for research rather than as a medicine, and the exact share of each peptide inside this pack is not published, which is stated openly rather than estimated.

CJC-1295 without DAC is a modified GHRH(1-29) fragment carrying four substitutions that protect it from fast enzyme breakdown, and Ipamorelin is a five amino acid peptide also known as NNC 26-0161. One acts as a GHRH analogue and the other as a selective ghrelin receptor agonist, so the two mechanisms are distinct even though both end at pituitary growth hormone release.

Reference values are about 30 minutes for CJC-1295 without DAC and about 2 hours for Ipamorelin. The Ipamorelin figure comes from human pharmacokinetic work that also reported a clearance of 0.078 litres per hour per kilogram, while the CJC figure is a review value. Nothing measured in the blend itself is published, so both numbers describe the individual peptides.

Add bacteriostatic water down the vial wall and do not shake it. Two millilitres give 2.5 mg per ml of total peptide, so 0.1 ml on a U-100 syringe equals 10 units and holds 250 mcg of blended material. Store the powder cold and dry and the solution at 2-8 C without freezing, and follow the short use window on the vial.

Work on unregulated growth hormone peptides describes fluid retention, joint discomfort, injection site reactions and, in some reports, rises in blood glucose and IGF-1. A 2026 review collects those findings across the class rather than for this blend. Both peptides are named or covered by class S2 of the WADA prohibited list, so they cannot be used in any tested setting.

It is usually documented next to the single-substance Ipamorelin and CJC-1295 without DAC vials, because comparing a one-receptor and a two-receptor exposure is the reason the blend exists. The CJC-1295 with DAC version on this line extends the same GHRH route with a longer acting peptide. There is no clinical data on running them together.

Yes. The 5 mg vial is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.